Pepgen Inc. (PEPG)

$18.55

+0.53

(+2.94%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $17.69
    $18.84
    $18.55
    downward going graph

    4.64%

    Downside

    Day's Volatility :6.1%

    Upside

    1.54%

    downward going graph
  • $3.72
    $18.72
    $18.55
    downward going graph

    79.95%

    Downside

    52 Weeks Volatility :80.13%

    Upside

    0.91%

    downward going graph

Returns

PeriodPepgen Inc.Sector (Health Care)Index (Russel 2000)
3 Months
51.05%
6.5%
0.0%
6 Months
162.68%
7.1%
0.0%
1 Year
175.96%
9.8%
0.0%
3 Years
51.43%
14.2%
-20.2%

Highlights

Market Capitalization
569.2M
Book Value
$5.53
Earnings Per Share (EPS)
-3.24
Wall Street Target Price
21.6
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-26.51%
Return On Equity TTM
-46.72%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-85.1M
Diluted Eps TTM
-3.24
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-2.87
EPS Estimate Next Year
-2.78
EPS Estimate Current Quarter
-0.74
EPS Estimate Next Quarter
-0.75

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Pepgen Inc.(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 16.44%

Current $18.55
Target $21.60

Technicals Summary

Sell

Neutral

Buy

Pepgen Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pepgen Inc.
Pepgen Inc.
6.5%
162.68%
175.96%
51.43%
51.43%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pepgen Inc.
Pepgen Inc.
NA
NA
NA
-2.87
-0.47
-0.27
NA
5.53
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pepgen Inc.
Pepgen Inc.
Buy
$569.2M
51.43%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Institutional Holdings

  • RA Capital Management, LLC

    32.97%

  • Suvretta Capital Management, LLC

    4.69%

  • Viking Global Investors LP

    4.57%

  • Perceptive Advisors LLC

    4.35%

  • Adage Capital Partners Gp LLC

    4.11%

  • HHG PLC

    3.60%

Company Information

Organization
Pepgen Inc.
Employees
65
CEO
Dr. James G. McArthur Ph.D.
Industry
Services

Discover More

FAQs